跳至主要内容
临床试验/EUCTR2006-005218-11-IT
EUCTR2006-005218-11-IT进行中(未招募)不适用

EFFECTIVENESS AND TOLERABILITY OF TREATMENT WITH CABERGOLINE IN PATIENTS WITH CUSHING S SYNDROME - CABERGOLINE IN CUSHING S SYNDROME

ASSOCIAZIONE ITALIANA ENDOCRINOLOGIA-METABOLISMO-IPOFISI0 个研究点开始时间: 2007年4月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1 Age above 18 and below 65 years 2 Diagnosis of Cushing s syndrome due to pituitary or adrenal tumor or ectopic ACTH secretion, performed by the standard diagnostic procedures evaluation of urinary cortisol secretion, cortisol circadian rhythm,low-dose and high-dose dexamethasone test, CRH and/or DDAVP test 3 Documentation of baseline cortisol urinary levels at least two times higher and less than four times lower than the upper limit of normal range 4 Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1 Pregnancy or Lactation; 2 Documented intolerance to cabergoline; 3 Liver, renal or cardiovascular insufficiency; 4 Specific conditions and/or tumor characteristics which require an immediate alternmative treatment aggressivity of the neoplasm or sever organ compromission

研究者

发起方
ASSOCIAZIONE ITALIANA ENDOCRINOLOGIA-METABOLISMO-IPOFISI

相似试验